Biosynthesis and regulatory mechanism of acarbose and its structural analogs: a review / 生物工程学报
Chinese Journal of Biotechnology
; (12): 605-619, 2022.
Article
en Zh
| WPRIM
| ID: wpr-927731
Biblioteca responsable:
WPRO
ABSTRACT
Acarbose is widely used as α-glucosidase inhibitor in the treatment of type Ⅱ diabetes. Actinoplanes sp. is used for industrial production of acarbose. As a secondary metabolite, the biosynthesis of acarbose is quite complex. In addition to acarbose, a few acarbose structural analogs are also accumulated in the culture broth of Actinoplanes sp., which are hard to remove. Due to lack of systemic understanding of the biosynthesis and regulation mechanisms of acarbose and its structural analogs, it is difficult to eliminate or reduce the biosynthesis of the structural analogs. Recently, the advances in omics technologies and molecular biology have facilitated the investigations of biosynthesis and regulatory mechanisms of acarbose and its structural analogs in Actinoplanes sp.. The genes involved in the biosynthesis of acarbose and its structural analogs and their regulatory mechanism have been extensively explored by using bioinformatics analysis, genetic manipulation and enzymatic characterization, which is summarized in this review.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Técnicas Genéticas
/
Acarbosa
/
Diabetes Mellitus Tipo 2
Límite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Biotechnology
Año:
2022
Tipo del documento:
Article